Meet the OCV doctors. Your network of oncology professionals...
Associate Professor Gary Richardson is the Director of Oncology Clinics Victoria, Director of Cabrini Academic Haematology & Oncology Services and an Associate Professor of Medicine at Monash University. He previously held the position of Director, Department of Medical Oncology & Clinical Haematology at Monash Medical Centre. He is a Fellow of the Royal Australasian College of Physicians. He trained at St Vincent’s Hospital, the Peter MacCallum Cancer Institute and the National Cancer Institute in the United States.
He is chairman of the Medical Oncology Group of Australia and president of the Private Cancer Physicians of Australia. He is an executive member of the Victorian Co-operative Oncology Group. He is a member of the American Society of Clinical Oncology; the American Association of Cancer Research; the American Association for the Advancement of Science; the Gynaecological Oncology Group; the International Association for the Study of Lung Cancer; and the Haematology Society of Australia.
A/Prof Richardson initiated and developed clinical research in haematology and oncology at Cabrini Health and is involved in the design, development and conduct of clinical trials. He is Director of Clinical Research in Medical Oncology and Haematology, and personally acts as principal investigator in many clinical studies in breast, lung, and gynaecological malignancy, as well as development of novel compounds for the treatment of cancer. He established the Family Cancer at Cabrini Clinic, the Oncology Service at Cabrini Brighton, and the apheresis service. He is published many research papers, abstracts, and book chapters. He is Chairman of Foundation 49, a Men’s Health Organisation sponsored by Cabrini Health, and is part of the Federal Government advisory board that developed the National Male Health Policy and the Victorian Men’s Health and Wellbeing Strategy.
Dr Andrew Haydon graduated from Monash University with Honours and then trained at the Alfred hospital. After obtaining his fellowship with the Royal Australasian College of Physicians in Medical Oncology, he undertook a PhD with Monash University and the Cancer Council of Victoria examining the epidemiological factors that influence survival in bowel cancer. Following this he was appointed as a full time staff specialist at the Alfred Hospital.
Dr Haydon holds honorary appointments as a senior lecturer in the Department of Medicine at Monash University and the University of Sydney, as well as being an honorary researcher with the Cancer Council of Victoria. He is involved in the running of multiple clinical trials at the Alfred Hospital.
Dr Haydon is a member of numerous multidisciplinary cancer meetings including The Victorian Melanoma service, the Cabrini colorectal cancer meeting the Alfred Head and Neck Cancer and Upper Gastro-intestinal cancer multidisciplinary meetings.
Dr Haydon is a member of the American Society of Clinical Oncology, the Medical Oncology Group of Australia, The Private Cancer Physicians of Australia, the Australasian Gastro-intestinal Trials Group and the ANZ Breast Cancer Trials Group. His interests are clinical trials, Upper and Lower Gastro-intestinal cancers, Head & Neck Cancer and Melanoma.
Dr Sanjeev Gill graduated from the University of Melbourne medical school & subsequently went on to study literature & Philosophy at Melbourne whilst working in general practice. He completed his specialist training in Medical Oncology and is a fellow of the Royal Australian college of Physicians. He was subsequently involved in clinical research for two years in the Tumour Targeting Laboratory of the Ludwig Institute for Cancer Research - investigating novel ways of targeting tumours. This was followed by two years primarily involved in Palliative Care before his appointment as a Medical Oncologist at the Alfred Hospital and Oncology Clinics Victoria.
Dr Gill holds an honorary appointment as a senior lecturer in the Department of Medicine at Monash University. He is involved in multiple clinical trials at both the Alfred and Cabrini.
He is a member of numerous multidisciplinary cancer meetings, the Cabrini colorectal and Urological cancer meetings and the Alfred Head and Neck Cancer, Lung cancer, Upper Gastro-intestinal cancer, Breast cancer and neuro oncology meetings.
Dr Gill is a member of the American Society of Clinical Oncology, European Society of Medical Oncology, the Medical Oncology Group of Australia, The Private Cancer Physicians of Australia, the Australasian Gastro-intestinal Trials Group and the ANZ Breast Cancer Trials Group. His major interests include clinical research, gastro-intestinal cancer, genitourinary cancer, breast cancer, lung cancer, neuro oncology and palliative care.
Esther Lin is a Fellow of the Royal Australasian College of Physicians. She completed her training through the Victorian Medical Oncology Training Group in Melbourne, and has also completed training in palliative care through the Victorian Palliative Medicine Training Program. Dr Lin is a member of the American Society of Clinical Oncology, the Medical Oncology Group of Australia, the Private Cancer Physicians of Australia, the Australia and New Zealand Society of Palliative Medicine, and the Australian Medical Association.
Dr Lin has presented at national medical oncology and palliative care conferences, and is involved in the conduct of clinical trials. She has also been involved in The University of Melbourne medical student teaching and examination programs.
Tess Schenberg is a medical oncologist with an interest in the management of patients at high risk of cancer.
She undertook a Fellow year in familial cancer at Peter MacCallum Cancer Centre and Monash Medical Centre and has extended this interest by undertaking a Doctorate through University of Melbourne. This is based at the Familial Cancer Centre at Peter MacCallum Cancer Centre where she also works as a clinician. Her research involves studying MRI screening outcomes in women at high risk of breast cancer.
Dr Schenberg has published several articles on familial cancer in peer reviewed journals and presented at national oncology and familial cancer conferences as well as being invited to attend ACCORD 2014. She is a former national trainee representative and current member of MOGA.